Literature DB >> 9022104

Atypical, severe toxoplasmic retinochoroiditis in elderly patients.

M W Johnson1, G M Greven, G J Jaffe, H Sudhalkar, A K Vine.   

Abstract

BACKGROUND: The diagnosis of toxoplasmic retinochoroiditis is based primarily on characteristic ocular findings, with supportive serologic evidence. Clinical recognition of atypical presentations is critical for timely antiparasitic drug therapy.
METHODS: Case histories were reviewed for seven presumed immunocompetent elderly patients with atypically severe (multifocal or diffuse or both) toxoplasmic retinochoroiditis. Three cases initially were misdiagnosed as acute retinal necrosis syndrome. The correct diagnosis was confirmed in each case by response to antiparasitic drug therapy, polymerase chain reaction studies of intraocular specimens, or histopathologic analysis.
RESULTS: The patients ranged in age from 69 to 82 years (median, 74 years). Only three patients had intercurrent medical conditions that may be associated with subtle immune dysfunction (diabetes mellitus and hepatitis C). The extensive necrotizing retinochoroiditis in each patient was nonhemorrhagic and not associated with occlusive retinal arteritis. Despite prompt response to antiparasitic drug therapy, prolonged treatment usually was required, and four patients had retinitis reactivation after discontinuing treatment. Significant visual loss accompanied the infection in most eyes.
CONCLUSION: Toxoplasmosis should be considered as a cause of multifocal or diffuse necrotizing retinitis or both in elderly patients. Older patients may be more susceptible to severe ocular Toxoplasma infections because of age-related decline in cell-mediated immunity and chronic underlying diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9022104     DOI: 10.1016/s0161-6420(97)30362-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  18 in total

1.  Severe bilateral necrotising retinitis caused by Toxoplasma gondii in a patient with systemic lupus erythematosus and diabetes mellitus.

Authors:  J H Yamamoto; D I Boletti; Y Nakashima; C E Hirata; E Olivalves; M M Shinzato; T S Okay; R M Santo; M I S Duarte; J Kalil
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

2.  Hypertensive iridocyclitis.

Authors:  E C Kim; T P Margolis
Journal:  Br J Ophthalmol       Date:  2006-07       Impact factor: 4.638

3.  Necrotising retinopathies simulating acute retinal necrosis syndrome.

Authors:  B Balansard; B Bodaghi; N Cassoux; C Fardeau; S Romand; F Rozenberg; N A Rao; P Lehoang
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

4.  Real-time polymerase chain reaction and intraocular antibody production for the diagnosis of viral versus toxoplasmic infectious posterior uveitis.

Authors:  Marie-Hélène Errera; Pablo Goldschmidt; Laurence Batellier; Sandrine Degorge; Emmanuel Héron; Laurent Laroche; José-Alain Sahel; Mark Westcott; Christine Chaumeil
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-07-06       Impact factor: 3.117

5.  Clinical manifestation and prognosis of active ocular toxoplasmosis in Iran.

Authors:  Farzan Kianersi; Afsaneh Naderi Beni; Zahra Naderi Beni
Journal:  Int Ophthalmol       Date:  2012-06-26       Impact factor: 2.031

6.  An ophthalmologist survey-based study of the atypical presentations and current treatment practices of ocular toxoplasmosis in India.

Authors:  Soumyava Basu; Jyotirmay Biswas; Uwe Pleyer; Avinash Pathangay; B Manohar Babu
Journal:  J Parasit Dis       Date:  2011-05-07

Review 7.  Diagnostic vitrectomy for infectious uveitis.

Authors:  Abdallah Jeroudi; Steven Yeh
Journal:  Int Ophthalmol Clin       Date:  2014

Review 8.  Diagnostic dilemmas in retinitis and endophthalmitis.

Authors:  J L Davis
Journal:  Eye (Lond)       Date:  2011-11-25       Impact factor: 3.775

Review 9.  Ocular toxoplasmosis II: clinical features, pathology and management.

Authors:  Nicholas J Butler; João M Furtado; Kevin L Winthrop; Justine R Smith
Journal:  Clin Exp Ophthalmol       Date:  2012-09-17       Impact factor: 4.207

10.  The antibody response in experimental ocular toxoplasmosis.

Authors:  Justus G Garweg; Matthias Boehnke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.